de novo cardiomyocytes within activated adult heart injury 
significant bottleneck cardiovascular regenerative medicine identification viable source stem/progenitor cells contribute new muscle ischaemic heart disease acute myocardial infarction therapeutic ideal-relative cell transplantation-would stimulate resident source thus avoiding caveats limited graft survival restricted homing site injury host immune rejection demonstrate mice adult heart contains resident stem progenitor cell population potential contribute bona fide terminally differentiated cardiomyocytes myocardial infarction reveal novel genetic label activated adult progenitors via re-expression key embryonic epicardial gene wilms tumour wt1 priming thymosin beta peptide previously shown restore vascular potential adult epicardium-derived progenitor cells injury cumulative evidence indicates epicardial origin progenitor population embryonic reprogramming results mobilization population concomitant differentiation give rise de novo cardiomyocytes cell transplantation confirmed progenitor source chromosome painting labelled donor cells revealed transdifferentiation myocyte fate absence cell fusion derived cardiomyocytes shown structurally functionally integrate resident muscle stimulation adult progenitor pool represents significant step towards resident-cell-based therapy human ischaemic heart disease 
